Lv71
4060 积分 2022-08-15 加入
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia
7天前
已完结
Frontline treatment of adults with newly diagnosed B-cell acute lymphoblastic leukaemia
8天前
已完结
How I treat adult Ph-positive ALL
10天前
已完结
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs
10天前
已完结
How I individualize treatment for chronic-phase CML
18天前
已关闭
Predicting Remission in Anti-PLA2R Antibody-Associated Membranous Nephropathy: A Secondary Analysis of the GEMRITUX, MENTOR and STARMEN Trials
19天前
已关闭
Predicting Remission in Anti-PLA2R Antibody-Associated Membranous Nephropathy: A Secondary Analysis of the GEMRITUX, MENTOR and STARMEN Trials
19天前
已关闭
Olverembatinib in chronic myeloid leukemia—Review of historical development, current status, and future research
21天前
已完结
Use of Rituximab in Childhood Idiopathic Nephrotic Syndrome
23天前
已完结
Anti-Nephrin Antibodies in Adult Chinese Patients with Minimal Change Disease and Primary Focal Segmental Glomerulosclerosis
1个月前
已完结
皖公网安备34019202002308
